Source:http://linkedlifedata.com/resource/pubmed/id/21143114
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-2-15
|
pubmed:abstractText |
The seven-spanning transmembrane G-protein coupled receptor CXCR4, which specifically binds to the chemokine CXCL12, is expressed on many cell types, including various types of tumour cells. CXCR4 plays a crucial role in organ-specific metastasis, directing migration of malignant cells expressing this receptor toward microenvironments where the cognate ligand is secreted. CXCL12 has a direct growth and survival-promoting effect for various cancer cells and enhances moreover tumour angiogenesis by recruiting endothelial progenitor cells to tumours. Drugs which modulate the CXCL12/CXCR4 axis are therefore promising candidates in anti-cancer therapies. CXCR4 is also a coreceptor for human immunodeficiency virus type 1 (HIV-1) X4 virus and, as such, plays an important role in virus entry into target cells. Hence, antiviral agents that bind to CXCR4 are expected to inhibit HIV-1 entry. Here we review the structure, mechanism of action and biological activity of the main CXCR4 antagonists (peptide inhibitors, non-peptide antagonists, neutralizing antibodies, modified analogues of CXCL12) and agonists (CXCL12 peptide analogues) and discuss the CXCL12/CXCR4 axis as an important target in development of anti-tumoral and anti-HIV-1 therapies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL12,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CXCR4,
http://linkedlifedata.com/resource/pubmed/chemical/Small Molecule Libraries
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1875-533X
|
pubmed:author | |
pubmed:copyrightInfo |
© 2011 Bentham Science Publishers Ltd.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
497-512
|
pubmed:meshHeading |
pubmed-meshheading:21143114-Antineoplastic Agents,
pubmed-meshheading:21143114-Chemokine CXCL12,
pubmed-meshheading:21143114-HIV Infections,
pubmed-meshheading:21143114-HIV-1,
pubmed-meshheading:21143114-Humans,
pubmed-meshheading:21143114-Neoplasms,
pubmed-meshheading:21143114-Peptides,
pubmed-meshheading:21143114-Receptors, CXCR4,
pubmed-meshheading:21143114-Small Molecule Libraries
|
pubmed:year |
2011
|
pubmed:articleTitle |
The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection.
|
pubmed:affiliation |
Department of Evolutionary Biology, University of Siena, Via Aldo Moro 2, 53100 Siena, Itlay. patrussi2@unisi.it
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|